Update: 07.06.2022
Last week: 21 week 2022 (23.05.2022 - 29.05.2022)
Last full month: Apr 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | |||||||||
| WoW | 2 221 | -13.8% | 54.3% | -2.9 | 1 060 394 | -16.1% | 82.1% | -2.2 | -9.3% |
| MoM | 8 817 | -34.6% | 53.5% | -4.3 | 4 250 643 | -36.0% | 81.2% | -3 | -29.4% |
| YTD | 53 958 | 2.6% | 55.5% | -4 | 25 421 549 | 32.6% | 82.7% | 1 | 9.9% |
| MAT | 118 977 | -16.6% | 54.0% | -7 | 51 855 633 | 11.1% | 80.9% | -0.5 | -5.7% |
| KAPSIKAM | |||||||||
| WoW | 20 728 | -3.2% | 2.7% | 0 | 8 699 840 | -3.8% | 2.9% | -0.1 | -1.7% |
| MoM | 169 728 | -20.9% | 2.7% | 0.2 | 74 220 018 | -20.8% | 2.9% | 0.4 | -27.1% |
| YTD | 462 543 | 0.7% | 2.7% | 0 | 196 069 973 | 2.2% | 2.9% | -0.3 | 0.0% |
| MAT | 1 068 298 | -11.8% | 2.7% | -0.1 | 443 092 357 | -6.8% | 2.9% | -0.3 | -7.5% |
| MILDRONATE | |||||||||
| WoW | 79 832 | -6.3% | 22.9% | -0.9 | 52 613 157 | -5.7% | 24.1% | -1 | -2.6% |
| MoM | 399 925 | -40.3% | 22.9% | 0.4 | 269 107 725 | -36.4% | 24.2% | 1.1 | -41.2% |
| YTD | 2 327 951 | 21.1% | 16.8% | 1.6 | 1 325 756 797 | 64.7% | 18.1% | 3.9 | 9.6% |
| MAT | 5 201 740 | 13.9% | 17.1% | 2 | 2 454 246 948 | 33.3% | 16.5% | 2.7 | 0.8% |
| SULFARGIN | |||||||||
| WoW | 2 820 | -13.7% | 0.8% | -0.1 | 1 431 110 | -12.9% | 1.1% | -0.2 | 0.4% |
| MoM | 11 103 | -27.8% | 0.8% | 0.1 | 5 749 879 | -26.5% | 1.1% | 0.2 | -35.6% |
| YTD | 66 510 | 6.2% | 0.9% | 0.1 | 33 306 531 | 13.0% | 1.1% | 0.1 | -4.4% |
| MAT | 168 034 | -12.0% | 0.9% | 0 | 83 586 943 | -1.4% | 1.2% | 0 | -7.8% |
| VIPROSAL | |||||||||
| WoW | 23 292 | 2.6% | 2.9% | 0.1 | 9 626 934 | 2.7% | 3.1% | 0.1 | -1.7% |
| MoM | 97 455 | -35.9% | 2.9% | -0.4 | 41 743 859 | -36.5% | 3.1% | -0.2 | -27.2% |
| YTD | 581 970 | 28.1% | 3.2% | 0.7 | 240 678 374 | 39.3% | 3.4% | 0.6 | 0.6% |
| MAT | 1 371 257 | 5.4% | 3.2% | 0.4 | 539 178 360 | 12.7% | 3.4% | 0.3 | -7.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 53 958 | 2.6% | 55.5% | -4 | 25 421 549 | 32.6% | 82.7% | 1 | 9.9% |
| KAPSIKAM | 462 543 | 0.7% | 2.7% | 0 | 196 069 973 | 2.2% | 2.9% | -0.3 | 0.0% |
| MILDRONATE | 2 327 951 | 21.1% | 16.8% | 1.6 | 1 325 756 797 | 64.7% | 18.1% | 3.9 | 9.6% |
| SULFARGIN | 66 510 | 6.2% | 0.9% | 0.1 | 33 306 531 | 13.0% | 1.1% | 0.1 | -4.4% |
| VIPROSAL | 581 970 | 28.1% | 3.2% | 0.7 | 240 678 374 | 39.3% | 3.4% | 0.6 | 0.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 118 977 | -16.6% | 54.0% | -7 | 51 855 633 | 11.1% | 80.9% | -0.5 | -5.7% |
| KAPSIKAM | 1 068 298 | -11.8% | 2.7% | -0.1 | 443 092 357 | -6.8% | 2.9% | -0.3 | -7.5% |
| MILDRONATE | 5 201 740 | 13.9% | 17.1% | 2 | 2 454 246 948 | 33.3% | 16.5% | 2.7 | 0.8% |
| SULFARGIN | 168 034 | -12.0% | 0.9% | 0 | 83 586 943 | -1.4% | 1.2% | 0 | -7.8% |
| VIPROSAL | 1 371 257 | 5.4% | 3.2% | 0.4 | 539 178 360 | 12.7% | 3.4% | 0.3 | -7.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 2 221 | -13.8% | 54.3% | -2.9 | 1 060 394 | -16.1% | 82.1% | -2.2 | -9.3% |
| KAPSIKAM | 20 728 | -3.2% | 2.7% | 0 | 8 699 840 | -3.8% | 2.9% | -0.1 | -1.7% |
| MILDRONATE | 79 832 | -6.3% | 22.9% | -0.9 | 52 613 157 | -5.7% | 24.1% | -1 | -2.6% |
| SULFARGIN | 2 820 | -13.7% | 0.8% | -0.1 | 1 431 110 | -12.9% | 1.1% | -0.2 | 0.4% |
| VIPROSAL | 23 292 | 2.6% | 2.9% | 0.1 | 9 626 934 | 2.7% | 3.1% | 0.1 | -1.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 8 817 | -34.6% | 53.5% | -4.3 | 4 250 643 | -36.0% | 81.2% | -3 | -29.4% |
| KAPSIKAM | 169 728 | -20.9% | 2.7% | 0.2 | 74 220 018 | -20.8% | 2.9% | 0.4 | -27.1% |
| MILDRONATE | 399 925 | -40.3% | 22.9% | 0.4 | 269 107 725 | -36.4% | 24.2% | 1.1 | -41.2% |
| SULFARGIN | 11 103 | -27.8% | 0.8% | 0.1 | 5 749 879 | -26.5% | 1.1% | 0.2 | -35.6% |
| VIPROSAL | 97 455 | -35.9% | 2.9% | -0.4 | 41 743 859 | -36.5% | 3.1% | -0.2 | -27.2% |
Abbreviations
WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1
MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1
YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date
MAT - Moving Annual Total - a period, being any 12 month period ending on the last week
MS - Market Share
Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs